SCHEMBL5136376

SCHEMBL5136376

COC(=O)C(C)(C)CC(=O)c1ccc(-c2ccc(N=C=O)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.39
CYP3A4 P08684 3/20 0.36
TSHR P16473 1/20 0.36
ALDH1A1 P00352 5/20 0.35
MAPT P10636 5/20 0.35
LMNA P02545 2/20 0.35
MAPK1 P28482 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
ALOX15 P16050 1/20 0.35
APEX1 P27695 1/20 0.35
RECQL P46063 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
HPGD P15428 3/20 0.32
HAO1 Q9UJM8 2/20 0.32
ERCC5 P28715 1/20 0.32
FEN1 P39748 1/20 0.32
DGAT1 O75907 2/20 0.32
KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4235426 0.81 SLC6A3 (0.39) GAACYP3A4TSHRALDH1A1SMN1; SMN2
SCHEMBL595610 0.79 GAA (0.43) GAACYP3A4TSHRALDH1A1MAPT
SCHEMBL1748176 0.77 GAA (0.40) GAACYP3A4ALDH1A1MAPTLMNA
SCHEMBL9733426 0.73 GAA (0.66) GAAALDH1A1MAPTLMNAMAPK1
SCHEMBL12121918 0.73 GSK3B (0.48) GAAALDH1A1MAPTLMNAMAPK1
SCHEMBL1748024 0.73 GSK3B (0.48) GAAALDH1A1MAPTLMNAMAPK1
SCHEMBL2763360 0.73 CYP3A4 (0.44) CYP3A4TSHRALDH1A1MAPTLMNA
SCHEMBL380738 0.73 SRC (0.53) GAACYP3A4TSHRALDH1A1MAPT
SCHEMBL1747913 0.72 ALDH1A1 (0.45) GAACYP3A4TSHRALDH1A1MAPT
SCHEMBL1747936 0.71 ALDH1A1 (0.51) GAACYP3A4TSHRALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874317-A2 PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY Bayer Pharmaceuticals Corporation (US) 2008-01-09 EP disclosed
WO-2006113919-A2 ARYL ALKYL ACID DERIVATIVES FOR AND USE THEREOF BAYER PHARMACEUTICALS CORPORATION (US) 2006-10-26 WO disclosed